Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity

被引:12
作者
Carpenter, GW
Breeden, L
Carr, DJJ
机构
[1] LOUISIANA STATE UNIV,MED CTR,DEPT MICROBIOL IMMUNOL & PARASITOL,NEW ORLEANS,LA 70112
[2] LOUISIANA STATE UNIV,MED CTR,CTR NEUROSCI,NEW ORLEANS,LA 70112
[3] LOUISIANA STATE UNIV,MED CTR,STANLEY S SCOTT CANC CTR,NEW ORLEANS,LA 70112
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1995年 / 17卷 / 12期
关键词
morphine; cytotoxic T-lymphocyte; chronic exposure; acute exposure;
D O I
10.1016/0192-0561(95)00094-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic exposure (11 days) to morphine has previously been shown to suppress splenic and peritoneal cytotoxic T-lymphocyte activity through mu-opioid receptors. The present study was undertaken to assess the effects of varying the frequency of exposure to morphine on cytotoxic T-lymphocyte activity in C3H/HeN mice immunized with C57BL/6 splenocytes. Mice subchronically treated with morphine (50.0 mg/kg) showed no measurable suppression of splenic natural killer activity or splenic or peritoneal cytotoxic T-lymphocyte activity. However, mice treated acutely with 50.0 mg/kg of morphine exhibited a significant suppression of peritoneal but not splenic cytotoxic T-lymphocyte activity. Naltrexone pretreatment of mice receiving an acute dose of morphine blocked the suppression, implicating the involvement of opioid receptors. Using column depletion chromatography, peritoneal exudate cells mediating cytotoxic T-lymphocyte activity were both CD4(+)CD8(-) and CD4(-)CD8(+). Collectively, the results suggest that the duration of opioid (morphine) exposure differentially affects peritoneal cytotoxic T-lymphocyte activity. These results may have important implications regarding immunity to viral infections in individuals who abuse drugs such as heroin.
引用
收藏
页码:1001 / 1006
页数:6
相关论文
共 16 条
[1]   MORPHINE-INHIBITION OF LYMPHOCYTE ACTIVITY IS MEDIATED BY AN OPIOID DEPENDENT MECHANISM [J].
BAYER, BM ;
DAUSSIN, S ;
HERNANDEZ, M ;
IRVIN, L .
NEUROPHARMACOLOGY, 1990, 29 (04) :369-374
[2]  
BRYANT HU, 1988, J PHARMACOL EXP THER, V245, P913
[3]   ROLE OF ADRENAL-CORTICAL ACTIVATION IN THE IMMUNOSUPPRESSIVE EFFECTS OF CHRONIC MORPHINE TREATMENT [J].
BRYANT, HU ;
BERNTON, EW ;
KENNER, JR ;
HOLADAY, JW .
ENDOCRINOLOGY, 1991, 128 (06) :3253-3258
[4]  
BUSSIERE JL, 1993, J PHARMACOL EXP THER, V264, P591
[5]   CHRONIC MORPHINE TREATMENT SUPPRESSES CTL-MEDIATED CYTOLYSIS, GRANULATION, AND CAMP RESPONSES TO ALLOANTIGEN [J].
CARPENTER, GW ;
GARZA, HH ;
GEBHARDT, BM ;
CARR, DJJ .
BRAIN BEHAVIOR AND IMMUNITY, 1994, 8 (03) :185-203
[6]   PRETREATMENT WITH BETA-FUNALTREXAMINE BLOCKS MORPHINE-MEDIATED SUPPRESSION OF CTL ACTIVITY IN ALLOIMMUNIZED MICE [J].
CARPENTER, GW ;
CARR, DJJ .
IMMUNOPHARMACOLOGY, 1995, 29 (02) :129-140
[7]  
CARR DJJ, 1993, J PHARMACOL EXP THER, V267, P9
[8]   MORPHINE-INDUCED SUPPRESSION OF CYTOTOXIC T-LYMPHOCYTE ACTIVITY IN ALLOIMMUNIZED MICE IS NOT MEDIATED THROUGH A NALTRINDOLE-SENSITIVE DELTA-OPIOID RECEPTOR [J].
CARR, DJJ ;
CARPENTER, GW .
NEUROIMMUNOMODULATION, 1995, 2 (01) :44-53
[9]   CENTRAL ALPHA-ADRENERGIC INVOLVEMENT IN MORPHINE-MEDIATED SUPPRESSION OF SPLENIC NATURAL-KILLER ACTIVITY [J].
CARR, DJJ ;
MAYO, S ;
GEBHARDT, BM ;
PORTER, J .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 53 (01) :53-63
[10]   VIRAL HEPATITIS ASSOCIATED WITH ILLICIT PARENTERAL USE OF DRUGS [J].
DISMUKES, WE ;
KARCHMER, AW ;
JOHNSON, RF ;
DOUGHERTY, WJ .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 206 (05) :1048-+